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Abstract
Background: Vitamin D depletion has been associated with increased rate of infections, lengthened hospital stay,
and worsened mortality for critically ill patients. The purpose of this study was to evaluate the prevalence and
variables associated with vitamin D deficiency in critically ill patients with severe traumatic injuries.
Methods: Critically ill adult patients admitted to the trauma intensive care unit (ICU) between June 2013 and June
2014, referred to the nutrition support service for enteral or parenteral nutrition, and had a serum 25-hydroxyvitamin D
(25-OH vitamin D) concentration determination were retrospectively evaluated. Patients were stratified as vitamin D
sufficient, insufficient, deficient, or severely deficient based on a 25-OH vitamin D concentration of 30–80, 20–29.9, 13.
1–19.9, and ≤13 ng/mL, respectively.
Results: One hundred and twenty-one patients out of 158 (76 %) patients were vitamin D deficient or severely deficient.
Thirty-one patients (20 %) were insufficient and 6 (4 %) had a normal 25-OH vitamin D concentration. 25-OH vitamin D
was determined 7.5 ± 5.1 days after ICU admission. African-Americans had a greater proportion of patients with deficiency
or severe deficiency compared to other races (91 versus 64 %, P = 0.02). Penetrating gunshot or knife stab injury,
African-American race, and obesity (elevated body mass index) were significantly associated with vitamin D
deficiency or severe deficiency: OR 9.23 (1.13, 75.40), 4.0 (1.4, 11.58), and 1.12 (1.03, 1.23), P < 0.05, respectively.
Conclusions: The majority of critically ill patients with traumatic injuries exhibit vitamin D deficiency or severe
deficiency. Penetrating injuries, African-American race, and obesity are significant risk factors for deficiency. Severity of
injury, extent of inflammation (elevated C-reactive protein concentration), or hospital admission during the winter
season did not significantly influence the prevalence of vitamin D deficiency.
Keywords: Vitamin D, Deficiency, Depletion, Trauma, Injury, Parenteral nutrition, Enteral nutrition, African-American,
Obesity
Background
Vitamin D is well known for its importance in calcium
and phosphorus homeostasis and bone formation. Recent
studies demonstrate that vitamin D may have an important
role in modulating the innate and adaptive immune
response to infectious pathogens including gram nega-
tive and positive bacteria, fungi, and mycobacteria [1].
Vitamin D deficiency in critically ill patients has been
associated with increased risk of infectious complications
and mortality [2–8] as it is an integral component to the
production of cathelicidin and other antimicrobial proteins
produced by macrophages and neutrophils [9]. The
synthesis of these antimicrobial proteins is highly
expressed at integumentary barrier sites such as the
respiratory epithelium [9].
Unfortunately, data regarding vitamin D depletion in
critically ill patients with severe multiple traumatic injuries
are limited due to studies that have incorporated these
patients as part of a larger population [10, 11], evaluated
patients months after the acute phase of their injury
[12, 13], or evaluated non-critically ill patients post
injury [14, 15]. Since infections, especially epithelial
barrier site infections such as pneumonia, are common
complications leading to death in approximately 20 %
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of critically ill trauma patients [16], it would be important
to ascertain if vitamin D deficiency is prevalent in this
population. The intent of this study was to ascertain the in-
cidence and risk factors for the development of vitamin D
deficiency among critically ill trauma patients who required
enteral or parenteral nutrition therapy and who were antici-
pated to have a prolonged intensive care unit (ICU) stay.
Methods
Design and patient selection
Adult patients, at least 18 years of age, with severe trau-
matic injuries and admitted to the ICU of the Presley
Trauma Center at Regional One Health in Memphis,
Tennessee, and referred to the Nutrition Support Service
(NSS) for enteral nutrition (EN) or parenteral nutrition
(PN) were eligible for study inclusion. The center is desig-
nated as a level 1 trauma center and serves the mid-south
region of the USA (western Tennessee, northern
Mississippi, Arkansas). Patients had a serum 25-hydroxy
vitamin D (25-OH vitamin D) determination while in the
ICU following patient referral to the NSS as part of their
routine metabolic assessment. Patients excluded from study
entry were those known to receive vitamin D beyond a
daily multivitamin supplement or those who received
chronic glucocorticoids, HIV medications [17], or other
medications known to increase vitamin D catabolism
[18, 19] prior to hospital admission. Females who were
pregnant were also excluded.
Study candidates were identified from the Nutrition
Support Service monitoring records from June 2013 to
June 2014. Winter was defined as November through
March based on the presence of reduced skin exposure
to ultraviolet light [11, 20]. Patients’ electronic medical
record and nutrition support service record were retro-
spectively reviewed for data retrieval. Injury severity
score [21] (ISS) was scored by trained nurses according
to the American Association for the Surgery of Trauma
scales for anatomic injury severity and recorded within
the data repository of the Tennessee trauma registry at
Regional One Health. The study was approved and con-
ducted in accordance with the guidelines established by the
University of Tennessee Health Science Center Institutional
Review Board and the Regional One Health Office of
Medical Research (study reference number 14-02924-XM).
Since this was a retrospective, non-interventional study, re-
quirement for written informed consent was waived.
Nutritional regimen and vitamin D intake
Patients were preferentially given enteral nutrition by a
nasogastric or orogastric feeding tube whenever possible.
Patients were assigned energy and protein goals of
25–32 kcal/kg/d and 2–2.5 g/kg/d per day, respect-
ively [22]. If the patient’s ISS was greater than 20 and en-
teral access was viable, an enteral formula (1.3 kcal/mL,
78 g protein/L) containing glutamine, arginine, dietary nu-
cleotides, and ω-3 fatty acids was initiated [23]. Other
enteral-fed patients received either a polymeric, high-
protein formula (1 kcal/mL, 62 g protein/L or 1 kcal/
mL, 93 g protein/L) or a diabetic formula (1.2 kcal/
mL, 60 g protein/L). Commercial enteral formulas
contained 400–533 IU of vitamin D3 per 1000 kcals.
Liquid protein supplements were also given per dis-
cretion of the NSS [22]. Patients requiring parenteral nu-
trition received an individualized prescription to meet
target energy and protein goals as a total nutrient admix-
ture via central venous access. Patients who required PN
received 200 IU of vitamin D3 daily as part of the intraven-
ous multivitamin additive to the PN admixture. Daily EN
and PN intakes were recorded for the first fourteen
days of nutrition therapy. Pre-resuscitation body weight
was used to determine target nutritional goals. Blood glu-
cose concentrations were maintained between 70 and
150 mg/dL with the use of intravenous regular human in-
sulin therapy as previously described [24–26].
Measured variables
Serum 25-OH vitamin D concentrations were obtained
at 0100 via a venous catheter approximately weekly
while the patient remained in the ICU and required PN
or EN. Serum 25-OH vitamin D concentrations were
assayed by the hospital laboratory via an automated chemi-
luminescent microparticle immunoassay (Architect System,
Abbott Laboratories, Abbott Park, IL, USA). The detection
limit was 8 ng/mL (20 nmol/L). Intra-assay and inter-assay
coefficient of variations were between 1.4 and 4.6 % for
concentrations ranging from 18 to 78 ng/mL (45 to
195 nmol/L) [27]. Verification studies for accurate concen-
tration determination ranged from 13 to 96 ng/mL (32 to
240 nmol/L) per the manufacturer recommendations [28].
Other laboratory tests were ordered by the patient’s primary
service or the NSS and performed by the hospital labora-
tory as part of the patient’s routine clinical care.
Classification of vitamin D insufficiency and defi-
ciency was based on the recommendations of the
Institute of Medicine [18]. A normal 25-OH vitamin D
concentration was established as 30 to 80 ng/mL. Pa-
tients with a 25-OH vitamin D of 20–29.9 ng/mL were
considered vitamin D insufficient whereas those with a
25-OH vitamin D of 13.1–19.9 ng/mL were catego-
rized as deficient and ≤13 ng/mL as severely deficient
[11, 18]. Patients with a serum 25-OH vitamin D con-
centration determination <20 ng/mL were prescribed
liquid ergocalciferol 50,000 IU once to three times
weekly via the feeding tube as previously described
[29]. Patients who received parenteral nutrition did
not receive additional liquid enteral vitamin D supple-
mentation beyond intravenous maintenance require-
ments in the parenteral nutrition solution until enteral
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access was established [29]. Only serum 25-OH vitamin D
measurements that were obtained prior to enteral liquid
vitamin D supplementation were used in this analysis.
Statistical analysis
Data analysis was conducted using SigmaPlot for
Windows, version 11.2 (Systat Software, Point Richmond,
VA) and SPSS version 22 (IBM Corporation, Chicago, IL).
The significance testing and reported probability values
(P) were two-sided for all variables. A P value of ≤0.05 was
defined as statistically significant. Continuous data were
expressed as mean ± standard deviation. The normality of
the distribution of the data was evaluated by the
Shapiro-Wilk test. Differences between vitamin D
depletion groups for continuous variables were ana-
lyzed using one-way analysis of variance with post
hoc pair-wise multiple comparisons by the Student-
Newman-Keuls test for normally distributed data or
Kruskal-Wallis one-way analysis of variance with
pair-wise multiple comparison by Dunn’s method for
non-normally distributed data. Categorical data were
evaluated by chi-square analysis. The paired t test or
Wilcoxon signed rank test was used for comparing
two simultaneous 25-OH vitamin D concentrations
within the same set of patients. A preliminary bivariate
correlation analysis of all collected categorical and
quantitative variables for the presence of vitamin D
deficiency was conducted to determine which covari-
ates to use in the binary logistic regression analysis.
Those variables that achieved a statistically significant
trend of P ≤ 0.15 were used in the multivariate model.




A total of 158 patients admitted to the trauma ICU were
evaluated. The majority of patients were male (82 %), ad-
mitted to the hospital due to a motor vehicle collision
(62 %), and survived (84 %). Patients exhibited an ISS
consistent with severe injury, had a markedly elevated
C-reactive protein (CRP) concentration, depressed
serum prealbumin concentration, and most were ad-
equate in body weight (body mass index ≥18.5 kg/m2).
Patients exhibited a mean elevated CRP of 22 mg/dL
with a concentration <10 mg/dL in only 32 patients
(20 % of the total population). None of the patients had
a normal CRP concentration (<1 mg/dL). The majority
of patients were either Caucasian (47 %) or African-
American (41 %) with the remaining patients of either
Hispanic or Asian descent. Other patient characteristics
among the vitamin D groups are given in Table 1.
Prevalence and associated risk factors for vitamin D
deficiency
The vast majority of patients (121, 77 %) were either
vitamin D deficient or severely deficient. Forty-six
patients (38 % of the total population) exhibited severe
deficiency. Only six patients (4 %) had a normal serum
25-OH vitamin D concentration. The remaining 31
patients (19 % of the total population) were vitamin D
insufficient. Age, sex, proportion of patients with a his-
tory of alcohol or illicit drug abuse, serum prealbumin
concentration, or hospital day of the 25-OH vitamin D
determination were not statistically different between
vitamin D groups (P =NS, Table 1). Although there were
no differences in body weight among the vitamin D
groups, body mass index (BMI) was significantly lower for
those with normal vitamin D concentrations compared to
the other groups (P = 0.033; Table 1).
There was no significant difference in serum 25-OH
vitamin D for those who were admitted in the winter
season (n = 66) versus the other months (n = 92): 17.4 ± 7.0
versus 17.4 ± 5.5 ng/mL, respectively (P = 0.642). Eighty
percent of patients admitted in the winter (53 out of 66)
were vitamin D deficient compared to 74 % of patients (68
out of 92) admitted in the remainder of the year (P =
0.456). Thirty-six percent of patients (24 out of 66) ad-
mitted in the winter were severely vitamin D deficient
compared to 24 % of patients (22 out of 92) admitted in
the other months of the year (P = 0.128).
There were no apparent correlative relationships between
serum 25-OH vitamin D concentration and extent of injury
as assessed by ISS (r = 0.046, P =NS, Fig. 1) or between the
amount of inflammation present as evaluated by serum C-
reactive protein concentration (r= 0.096, P =NS; Fig. 2). A
greater proportion of patients with penetrating injuries
(gunshot and knife stab wounds) experienced severe
vitamin D deficiency (Table 1; P = 0.001). Race influenced
serum 25-OH vitamin D concentrations as African-
Americans had a significantly lower serum 25-OH vitamin
D concentration than non-African-Americans (15.4 ± 4.2
versus 18.7 ± 6.9 ng/mL, P = 0.001; Fig. 3) and demon-
strated a greater proportion of patients with severe vitamin
D deficiency (Table 1; P = 0.004). Binomial logistic re-
gression analysis indicated that admitting diagnosis of a
gunshot or knife stab wound, African-American race,
and increasing body mass index were the most statisti-
cally significant covariates associated with vitamin D
deficiency (Table 2). Admission diagnosis of a gunshot
or knife stab wound was also significantly associated
with severe vitamin D deficiency; however, the associ-
ation with African-American race and body mass index
did not achieve statistical significance with severe vitamin
D deficiency (Table 2).
Serum 25-OH vitamin D concentrations were ob-
tained 7.7 ± 5.1 days following admission to the ICU.
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Table 1 Patient characteristics
Variable Normal Insufficient Deficient Severely deficient P ≤
25-OH vitamin D concentration range, ng/mL 30–80 20–29.9 13.1–19.9 ≤13
N 6 31 75 46
Male/female, n/n 5/1 27/4 61/14 37/9 0.885
Race
Caucasian, n (%) 5 (83 %) 22 (71 %) 34 (45 %) 13 (28 %) 0.004
African-American, n (%) 1 (17 %) 5 (16 %) 32 (43 %) 27 (59 %)
Hispanic/other, n (%) 0 (0 %) 4 (13 %) 9 (12 %) 6 (13 %)
Etiology for admission
MVA, n (%) 1 (17 %) 21 (68 %) 48 (64 %) 18 (39 %) 0.001
GSW/KSW, n (%) 0 (0 %) 1 (3 %) 14 (19 %) 19 (41 %)
Fall/Assault, n (%) 5 (83 %) 6 (19 %) 9 (12 %) 6 (13 %)
Other, n (%) 0 (0 %) 3 (10 %) 4 (5 %) 3 (7 %)
Age, years 60 ± 30 46 ± 22 45 ± 18 43 ± 17 0.243
Weight, kg 70 ± 20 85 ± 17 88 ± 23 87 ± 19 0.206
BMI, kg/m2 22 ± 5 27 ± 4 28 ± 7 29 ± 5 0.033
Injury severity score 25 ± 6 30 ± 14 27 ± 14 29 ± 13 0.399
C-reactive protein, mg/dL 20.4 ± 12.0 18.5 ± 12.0 22.1 ± 12.5 23.7 ± 11.9 0.380
Prealbumin, mg/dL 8.9 ± 5.6 9.9 ± 8.2 8.7 ± 4.1 8.5 ± 3.7 0.989
Alcohol abuse, n (%) 1 (17 %) 10 (32 %) 17 (23 %) 12 (26 %) 0.720
Admitted Nov–Mar, n (%) 3 (50 %) 10 (32 %) 29 (39 %) 24 (52 %) 0.300
Serum ionized calcium, mmol/L 1.19 ± 0.06 1.17 ± 0.06 1.18 ± 0.09 1.16 ± 0.07 0.407
Serum phosphorus, mg/dL 2.9 ± 0.3 3.8 ± 0.8 3.6 ± 1.0 3.6 ± 1.0 0.055
25-OH vitamin D, ng/mL 39.2 ± 7.3 23.2 ± 3.0 16.0 ± 2.2 12.8 ± 0.5 0.001
Hospital day of vitamin D determination, days 6.2 ± 2.9 9.8 ± 5.6 7.4 ± 5.3 7.1 ± 4.5 0.077
BMI body mass index, GSW gunshot wound, KSW knife stab wound, Mar March, MVA motor vehicle accident, N number of patients, Nov November, OH hydroxy
*Significantly different (P ≤ 0.05) from the other groups
Fig. 1 Relationship between serum 25-OH vitamin D concentration
and severity of injury (r= 0.046, P= 0.571). The insignificant inverse linear
relationship was expressed as 25-OH vitamin D concentration =
18.0 − (0.02 × injury severity score)
Fig. 2 Lack of influence of extent of inflammation as evidenced by
C-reactive protein concentration upon serum 25-OH vitamin D
concentration (r = 0.046, P = 0.571). The relationship was
described by 25-OH vitamin D concentration = (−0.05 × C-reactive
protein concentration) + 18.6
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No significant correlative relationship was observed be-
tween serum 25-OH vitamin D concentration and hospital
day for its determination (Fig. 4; r = 0.081, P = 0.315).
Serum 25-OH vitamin D concentration in those patients
whose measurements were done 2 to 4 days post ad-
mission to the ICU (mean 2.9 ± 0.9 days post admis-
sion, n = 47) were not substantially different from those
who were measured at least 5 days following admission
to the ICU (mean 9.5 ± 5.9 days post admission, n = 111):
16.2 ± 4.5 versus 17.9 ± 6.7 ng/mL for each time group,
respectively (P = 0.231). Ten patients with vitamin D defi-
ciency or severe deficiency who were receiving maintenance
vitamin D therapy from their nutritional formula had a
second concentration obtained prior to implementation of
enteral vitamin D therapy 10.4 ± 4.6 days after the initial
determination. Serum concentrations were minimally
changed (14.3 ± 1.9 versus 15.4 ± 2.8 ng/mL, respect-
ively, P = 0.158). Similar results were observed for 14
patients with vitamin D insufficiency with a repeated
determination 8.3 ± 3.5 days following the initial obser-
vation (23.2 ± 3.2 versus 24.2 ± 5.8 ng/mL, P = 0.401).
Clinical outcomes associated with vitamin D deficiency
Clinical outcomes of survival, ICU length of stay, hospital
length of stay, and proportion of patients that developed a
nosocomial infection (e.g., pneumonia, sepsis, wound infec-
tion, intra-abdominal abscess, urinary tract infection) while
in the ICU were not statistically significant among groups
with varying degrees of vitamin D depletion (Table 3).
However, a trend towards a shorter ICU length of stay
(mean of 14 versus 21 to 23 days for the other groups, re-
spectively; P = 0.053) was observed for those patients who
had normal vitamin D stores (Table 4). Unfortunately, clin-
ical outcome comparisons between groups (Table 4) were
confounded by provision of supplemental vitamin D ther-
apy in patients with vitamin D deficiency which limited
interpretation regarding the clinical impact of vitamin D
depletion. However, clinical outcomes among the extent of
vitamin D depletion groups were not attributed to any
differences in calorie, protein, or intrinsic vitamin D intake
from the EN or PN (Table 4).
Discussion
Vitamin D depletion has been associated with an in-
creased rate of infections, lengthened hospital stay, and
worsened mortality for critically ill patients [2–8, 30, 31].
These worsened outcomes were potentially related to the
discovery that the synthesis of 1,25 - dihydroxy [(OH)2]
vitamin D within immune cells derived from circulating
25-OH vitamin D enhances antibacterial activity by
triggering production of cathelicidin and other anti-
microbial peptides [9, 32, 33]. Thus, the presence of
vitamin D deficiency would result in decreased avail-
ability of substrate for 1,25 -(OH)2 vitamin D synthesis
Fig. 3 Mean serum 25-OH vitamin D concentration (depicted by the
solid horizontal line) and range for African-Americans and those of
non-African-American race (15.4 ± 4.2 versus 18.7 ± 6.9 ng/mL,
respectively, P < 0.001)
Table 2 Variables associated with vitamin D deficiency
Vitamin D deficiency and severe deficiency (25-OH vitamin D <20 ng/mL)
Variable OR P
GSW/KSW 9.23 (1.13, 75.40) 0.038
African-American race 4.02 (1.40, 11.58) 0.010
Body mass index 1.12 (1.03, 1.23) 0.010
Serum C-reactive protein 1.04 (1.00, 1.08) 0.062
Severe vitamin D deficiency (serum 25-OH vitamin D ≤13 ng/mL)
Variable OR P
GSW/KSW 3.52 (1.49, 8.23) 0.004
African-American race 1.88 (0.87, 4.07) 0.109
GSW gunshot wound, KSW knife stab wound, OH hydroxy, OR odds ratio
Fig. 4 Influence of intensive care unit (ICU) day upon serum
25-OH vitamin D concentration (r = 0.081, P = 0.315). The
insignificant positive relationship was depicted by 25-OH
vitamin D concentration = 16.6 + (0.1 × ICU day)
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[34] and, ultimately, decreased production of anti-
microbial peptides. The objective of this study was to
ascertain the prevalence and risk factors for vitamin D
deficiency for critically ill patients with severe trau-
matic injuries who are anticipated to have a prolonged
ICU length of stay and who require specialized nutri-
tion therapy.
Our data indicated that the majority (77 %) of critically
ill patients with traumatic injuries are either deficient or
severely deficient with only 4 % of patients having a normal
25-OH vitamin D serum concentration. Our data also indi-
cated that those with penetrating injuries due to a gunshot
or knife stab wound, of African-American descent, or an
increased body mass index (i.e., obesity) were at greater
risk for exhibiting vitamin D deficiency. Our finding re-
garding the marked and nearly universal prevalence of vita-
min D insufficiency or deficiency was important due to the
limited amount of data for critically ill patients with severe
traumatic injuries [10, 11, 35].
The etiology for the high incidence of vitamin D defi-
ciency in our population was likely multifactorial. African-
Americans have historically been noted to be at risk for
vitamin D deficiency due to increased melanin pigment
content resulting in a decreased synthesis of pre-vitamin
D3 in the skin during exposure to ultraviolet radiation [34].
Recent data also indicate that serum vitamin D-binding
protein concentrations are lower in African-Americans
than American Caucasians due to genetic polymorphism
differences [36]. Vitamin D-binding protein accounts for
85 to 90 % of total circulating 25-OH vitamin D with
serum albumin binding accounting for an additional 10 to
15 % [36]. Thus, race-specific vitamin D-binding protein
concentrations differences [36, 37], independent of critical
illness, may have also contributed at least in part, for the
observed significant decrease in serum 25-OH vitamin D
concentration for African-Americans in our trauma
patient population.
Since humans obtain 40 to 50 % of their vitamin D
requirements from ultraviolet radiation exposure to
sunlight [38], it would be anticipated that the winter
months would result in a higher incidence of vitamin
D deficiency due to a decrease in outdoor activity as
well as a seasonal change in the angle refraction of
light from the sun [11, 20]. Although others suggest a
profound 50 % increase in the presence of vitamin D
deficiency in critically ill patients when comparing
winter month admissions to a late summer month [8],
we found only a modest, statistically insignificant, 16 %
and 12 % increase in the incidence of vitamin D defi-
ciency and severe deficiency, respectively. These data
suggest other factors outside of pre-hospitalization
sunlight exposure may be more important in the
pathogenesis of vitamin D deficiency for our critically
ill population.
Table 3 Clinical outcomes
Variable Normal Insufficient Deficient Severely deficient P ≤
25-OH vitamin D concentration range, ng/mL 30–80 20–29.9 13.1–19.9 ≤13
N 6 31 75 46
Survived, n (%) 5 (83 %) 27 (87 %) 64 (85 %) 36 (80 %) 0.835
ICU length of stay, days 14 ± 7 23 ± 9 23 ± 18 21 ± 16 0.053
Hospital length of stay, days 22 ± 13 38 ± 20 35 ± 24 38 ± 22 0.132
Infection, n (%) 6 (100 %) 28 (90 %) 54 (72 %) 35 (76 %) 0.108
Hospital day of infection, days 6 ± 2 9 ± 7 6 ± 5 8 ± 6 0.215
ICU intensive care unit, N number of patients, OH hydroxy
Table 4 Vitamin D intake and nutrition therapy
Variable Normal Insufficient Deficient Severely deficient P ≤
25-OH vitamin D concentration range, ng/mL 30–80 20–29.9 13.1–19.9 ≤13
N 6 31 75 46
Received supplemental ergocalciferol, n (%) 0 (0 %) 5 (16 %) 57 (76 %) 35 (76 %) 0.001
Day ergocalciferol started, days – 16 ± 4 10 ± 7 11 ± 8 0.286
Ergocalciferol duration, days – 27 ± 24 15 ± 13 20 ± 17 0.095
Caloric intake, kcals/days 1060 ± 524 1397 ± 473 1386 ± 562 1420 ± 412 0.527
Protein intake, g/days 109 ± 41 114 ± 41 106 ± 41 108 ± 30 0.797
EN/PN, n/n 6/0 26/5 55/20 33/13 0.526
Vitamin D from EN/PN, IU/day 818 ± 279 953 ± 326 769 ± 316 800 ± 280 0.084
EN enteral nutrition, N number of patients, PN parenteral nutrition, OH hydroxy
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Obesity, in health as well as in critical illness, may also
play a role in the development of vitamin D insufficiency
and deficiency [37, 39–41]. It has been proposed that
decreased 25-OH vitamin D concentrations in obese
patients occur due to its sequestration within body fat
compartments [41] particularly in those with an increased
waist to hip ratio [39, 40]. Patients with a normal 25-OH
vitamin D had a significantly lower body mass index than
the vitamin insufficient and deficient groups (Table 1).
The role of obesity in modulating circulating 25-OH
vitamin D concentrations during critical illness and its im-
pact upon clinical outcomes warrants further investigation.
There is an abundant amount of emerging literature
that critical illness, per se, is a causative factor in the
development of vitamin D insufficiency and deficiency
[1–8, 10, 11, 29, 30, 35]. Serum 25-OH vitamin D con-
centrations have been demonstrated to decrease as early
as 3 days post ICU admission and remain depressed for
at least 10 days [30]. Inflammatory stress states, including
sepsis, results in decreases in serum vitamin D-binding
protein concentration [1, 8, 42] which ultimately results in
a decrease in 25-OH vitamin D concentration. Our popu-
lation exhibited a high level of stress and inflammation as
evidenced by a high ISS and elevated CRP concentrations
(Table 1).
The most appropriate time post admission for assessing
the presence of vitamin D deficiency for critically ill
patients is controversial. Fluid resuscitation may acutely
lower 25-OH vitamin D concentration. Serial 25-OH
vitamin D concentrations in post cardiopulmonary by-
pass surgery patients were reduced by 35 % during the
procedure but returned to within ~10 % of baseline
concentrations within 24 h [43]. Seventy percent of our
25-OH vitamin D observations were conducted at least
5 days after admission to the ICU, and none were mea-
sured any earlier than 2 days post admission as we
attempted to avoid obtaining serum concentrations during
fluid resuscitation.
It also has been recommended that multiple determina-
tions be performed due to assay variability and possible di-
urnal variation in 25-OH vitamin D concentrations [44].
However, the influence of diurnal variation was eliminated
in our study as vitamin D concentrations were obtained at
about the same time (0100) for all patients. Twenty-four
patients had a second 25-OH vitamin D determination
several days later (and prior to supplemental vitamin D
therapy [29]) which indicated a clinically irrelevant differ-
ence in concentration of ~1 ng/mL. Taken together, these
data indicate that the observed high prevalence of vitamin
D insufficiency and deficiency for critically ill patients with
traumatic injuries, based on serum 25-OH vitamin D con-
centration, was correctly quantitated.
No statistically significant difference was noted among
groups for infection rates; however, it is possible that
clinical outcomes in those with vitamin D deficiency
may have been confounded by the provision of vitamin
D therapy per the current practice of the Nutrition Sup-
port Service at our institution (Table 4) [29]. Patients
with a normal 25-OH vitamin D concentration and did
not require vitamin D supplementation had a decreased
ICU length of stay that approached statistical signifi-
cance (P = 0.053) compared to the other groups
(Table 3); however, these data should also be inter-
preted with caution due to the low number of subjects
with a normal serum 25-OH vitamin D concentration.
Although numerous studies suggest a relationship be-
tween vitamin D deficiency and increased mortality and
infectious complications for critically ill patients [2–8], it
is still considered controversial and unclear whether a low
serum 25-OH vitamin D concentration may be a signal of
an activated immune system during the acute phase of
critical illness rather than a risk factor for impaired im-
munity or survival [32, 35]. It also has been suggested that
it is not entirely clear if a poor vitamin D status is more of
an indicator of an unhealthy lifestyle, multiple risk factors
for morbidity, and consequently associated with poorer
prognostic outcomes [45].
This study has limitations. This study was performed
at a single medical center and lacks a comparative normal
healthy control group from our region of the country. Pre-
morbid vitamin D concentrations for the patients were not
available. The assay for vitamin D-binding protein was
unavailable at our institution which could have provided
further insight into the amount of bioavailable vitamin D
with each group. However, lack of vitamin D-binding pro-
tein concentrations will not alter the interpretation of these
data as 25-OH vitamin D and binding protein concentra-
tions tend to parallel each other [14, 36]. The timing of the
initial and subsequent 25-OH vitamin D assays post admis-
sion to the ICU was allowed to be within a target range of
about 2 weeks post admission (excluding the immediate
resuscitation period) and not precisely standardized by day
of ICU admission among groups. A greater number of pa-
tients with a normal 25-OH vitamin D concentration would
have been more meaningful for comparative group evalua-
tions. Finally, comparison of clinical outcomes for the de-
pleted and severely depleted patient groups were likely
skewed by the administration of supplemental vitamin D
therapy. A separate analysis of groups without provision of
vitamin D supplementation is warranted for examining the
extent of vitamin D depletion upon clinical outcomes.
Conclusions
The majority of critically ill patients with traumatic in-
juries, particularly those with penetrating wounds, and
those with obesity or of African-American race are at
greater risk for deficiency. Severity of injury, extent of
inflammation, or hospital admission during the winter
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season did not significantly influence the prevalence
of vitamin D deficiency. Whether vitamin D supple-
mentation will improve clinical outcomes for this
population requires further research.
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